Neoplasm

Showing 1 - 25 of 105

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)

Not yet recruiting
  • Neoplasm
  • Caregivers
  • Sham VR
  • Active VR
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 26, 2023

Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

Active, not recruiting
  • Neoplasm
  • Beijing, China
  • +5 more
Jan 31, 2023

Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

Completed
  • Neoplasm
  • Chuo-Ku, Japan
  • +1 more
Nov 3, 2022

Metastatic Melanoma, Skin Cancer, Tumor Trial in New York (ADI PEG 20)

Completed
  • Metastatic Melanoma
  • +2 more
  • ADI PEG 20
  • New York, New York
  • +1 more
Oct 3, 2022

Tumor Trial in Quebec (SAR444200, Cemiplimab)

Recruiting
  • Neoplasm
  • SAR444200
  • Cemiplimab
  • Providence, Rhode Island
  • +3 more
Oct 17, 2022

Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)

Completed
  • Cancer
  • Neoplasm
  • NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
  • Frankfurt, Germany
    Krankenhaus Nordwest
Oct 3, 2022

Samples From People With Unanticipated Response, Significant

Enrolling by invitation
  • Cancer
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)

    Completed
    • Neoplasm
    • Solid Tumors
    • Camperdown, New South Wales, Australia
    • +1 more
    Jul 18, 2022

    Tumor Trial (Tusamitamab ravtansine)

    Not yet recruiting
    • Neoplasm
    • Tusamitamab ravtansine
    • (no location specified)
    Jun 22, 2022

    Tumor Trial in Worldwide (Isatuximab SAR650984, Atezolizumab)

    Completed
    • Neoplasm
    • Santa Monica, California
    • +26 more
    Jun 8, 2022

    Specimen Banking for People With Tumors of Central Nervous

    Recruiting
    • Brain Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Apr 7, 2022

      Cancer, Tumors, Tumor Trial in Worldwide (BMS-986226, Nivolumab, Ipilimumab)

      Completed
      • Cancer
      • +3 more
      • Boston, Massachusetts
      • +12 more
      Mar 11, 2022

      Tumor Trial in Houston (SGT-53, Topotecan, Cyclophosphamide)

      Suspended
      • Neoplasm
      • SGT-53
      • +2 more
      • Houston, Texas
        Texas Children's Hospital
      Feb 7, 2022

      Barrett's Esophagus and Early Esophageal Cancer

      Terminated
      • Barrett Esophagus
      • +4 more
      • CSA System (CryoSpray AblationTM System)
      • CryoSpray Ablation
      • Baltimore, Maryland
        University of Maryland School of Medicine and Greenebaum Cancer
      Jan 25, 2022

      Cancer, Tumor Metastasis, Radiation Oncology Trial run by the NCI (Radiation Therapy, ECI301)

      Terminated
      • Cancer
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Nov 30, 2021

      Drug Interactions Before Antitumor Treatment Initiation

      Active, not recruiting
      • Neoplasm
        • Paris, France
          APHP -Cochin Hospital and Georges Pompidou European Hospital
        Dec 20, 2021

        Patients Who Have Received Gene Therapy Or Gene Marked Products

        Recruiting
        • Severe Combined Immunodeficiency
        • +4 more
        • Venipuncture
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Dec 10, 2021

        Tumor, Skull Base Tumor Trial in New York (5-Aminolevulinic acid Hydrochloride)

        Recruiting
        • Neoplasm
        • Skull Base Neoplasm
        • 5-Aminolevulinic acid Hydrochloride
        • New York, New York
        • +2 more
        Oct 28, 2021

        Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

        Recruiting
        • Cancer
        • +3 more
        • Amersfoort, Utrecht, Netherlands
        • +34 more
        Oct 26, 2021

        Tumor Trial in Worldwide (PF-05212384 (gedatolisib), Docetaxel, Cisplatin)

        Completed
        • Neoplasm
        • PF-05212384 (gedatolisib)
        • +3 more
        • Birmingham, Alabama
        • +28 more
        Sep 9, 2021

        Tumor Trial in Tampa (TBCCN-developed educational materials, NCI-developed educational materials)

        Completed
        • Neoplasm
        • TBCCN-developed educational materials
        • NCI-developed educational materials
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Sep 17, 2021

        Family and Personal History of Malignancy in Intraductal

        Completed
        • Pancreatic Cancer
        • Neoplasm
          • New York, New York
            Columbia University Irving Medical Center
          Jul 2, 2021

          Sepsis, Septic Shock, Tumor Trial in Amman (Procalcitonin Levels, Control)

          Recruiting
          • Sepsis
          • +3 more
          • Procalcitonin Levels
          • Control
          • Amman, Jordan
            King Hussein Cancer Center
          Feb 17, 2021

          Tumor Trial in Japan (Olaratumab, Doxorubicin)

          Completed
          • Neoplasm
          • Chuo-Ku, Japan
          • +3 more
          Feb 9, 2021

          Tumor, Cancer, Tumors Trial in United States (TKI258)

          Completed
          • Neoplasm
          • +2 more
          • Scottsdale, Arizona
          • +3 more
          Dec 17, 2020